secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2025-05-28T23:59:59+00:00
Accession:  0001171843-25-003505
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptose shareholders approve reverse stock split and stock plan amendment; meeting adjourned for auditor search
--------------------------------------------------------------------------------

- All 7 director nominees re-elected with ≥97.69% votes for.
- Shareholders approved amendment to 2021 stock plan increasing reserved shares by 458,126.
- Reverse stock split authorized (1:2 to 1:20) at board discretion; ratio and date TBD.
- Meeting adjourned to allow search for successor auditor to KPMG LLP; new meeting date to be set.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000117184325003505/0001171843-25-003505-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000117184325003505/f8k_052825.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-003505

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer